SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
Background: The prognosis of advanced osteosarcoma (OS) has remained stagnant in last decades, requiring the identification of novel therapeutic targets. Recently, much attention was paid to the role of squalene epoxidase (SQLE), a rate-limiting enzyme in cholesterol metabolism, in the field of onco...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Molecular and Cellular Probes |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0890850824000458 |